Definitive Contract 75N91025C00045
Award Date 9/5/25
Potential Completion Date 9/4/26
Potential Value $506K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
GRANDVIEW, OH 43212, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This $354,994.00 federal contract award was made by the National Cancer Institute (NCI) to Columbus Nanoworks, Inc., a small business biotechnology research company, for a Phase I Small Business Innovation Research (SBIR) project titled "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)." The project is focused on developing a quantum-based diagnostic for microRNA in inflammatory breast cancer, which aligns with NCI's broader research objectives in cancer diagnostics and...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the small business prime contractor Columbus Nanoworks, Inc. The $299,999 Firm Fixed Price contract is for the SBIR Phase I research and development of "Imaging for Cancer Immunotherapies-Moonshot," which is focused on advancing imaging technologies to support cancer immunotherapies. The work is being performed in Grandview, Ohio. Columbus Nanoworks is a for-profit biotechnology research company...
- <p>The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanoscale Corporation for the development of a rapid in vitro screening assay to detect cancer biomarkers in urine and blood. The $150,000.00 firm-fixed-price contract has a completion date of May 2, 2013. This SBIR contract is part of the NCI's efforts to support small businesses in the development of innovative cancer-related technologies.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Keystone Nano Inc., a small disadvantaged business. The contract, valued at $198,510.00, is for the development of "Multifunctional Nanojackets for Breast Cancer Treatment." The contract was awarded on September 24, 2010, with a completion date of July 29, 2011. This SBIR Phase I contract is focused on early-stage research and...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...
- The National Cancer Institute awarded a $1,995,119 firm-fixed-price Phase II SBIR contract to Boston Cell Standards Inc., a for-profit manufacturer of medical devices, diagnostics, and related services. The contract, which is set aside for small businesses, is to develop quantitative traceable reference materials for use in cancer detection and diagnostics. This award builds on a previous $385,889 Phase I SBIR contract with the National Cancer Institute. Boston Cell Standards has also received...
- This is a $1,499,656.00 Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services (HHS), to Columbus Nanoworks, Inc., a small business manufacturer of nanomaterials. The contract is for the development of fluorescent nanodiamonds for in vitro and in vivo biological imaging, under the Small Business Innovation Research (SBIR) program. The work will be performed primarily in Grandview, Ohio. This...
- The U.S. government awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Evident Technologies, Inc., a small business located in Troy, NY. The $172,216.00 fixed-price contract is for the development of quantum dot nanotechnology to quantify marker expression in breast cancer. The contract was awarded on August 2, 2006 by a U.S. government agency, with a completion date of August 1, 2007. This SBIR Phase I contract is part of the agency's initiatives to support...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase II contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of a quantum dot Förster resonance energy transfer (FRET) immunoassay to quantify intramolecular epitopes of analytes in tissue sections. The definitive, firm-fixed price contract has a potential value of $2,000,000.00 and a...